Eagle Pharmaceuticals Inc... (EGRX)
OTC: EGRX
· Real-Time Price · USD
1.25
-0.25 (-16.67%)
At close: Apr 04, 2025, 3:30 PM
Eagle Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 64.65M | 66.31M | 60.7M | 65.9M | 74.14M | 115.87M | 42.32M | 39.85M | 48.12M | 41.25M |
Cost of Revenue | 16.86M | 17.3M | 19.87M | 23.65M | 23.66M | 27.75M | 12.31M | 8.26M | 10.76M | 10.86M |
Gross Profit | 47.79M | 49.01M | 40.83M | 42.25M | 50.47M | 88.12M | 30.01M | 31.59M | 37.37M | 30.39M |
Operating Income | 10.3M | 6.19M | 9.47M | -2.31M | 2.2M | 59.83M | 5.9M | -10.18M | 10.82M | -3.77M |
Interest Income | 195K | 212K | 317K | n/a | 244K | 154K | 165K | 197K | 163K | 35K |
Pretax Income | 9.3M | 10.23M | 13.3M | -45K | -5.87M | 57.66M | 1.22M | -12.66M | 5.55M | 1.34M |
Net Income | 5.16M | 5.75M | 8.16M | -3.51M | -9.45M | 44.06M | -6.2M | -5.62M | 3.61M | -421K |
Selling & General & Admin | 27.65M | 27.96M | 24.15M | 23.46M | 36.83M | 22.18M | 20.32M | 18.48M | 16.64M | 19.88M |
Research & Development | 9.83M | 9.27M | 7.22M | 9.33M | 11.44M | 6.11M | 3.79M | 23.29M | 9.91M | 14.29M |
Other Expenses | n/a | -238K | 5.5M | -7.92M | -7.76M | -1.96M | -4.45M | -2.28M | -5.01M | 5.5M |
Operating Expenses | 37.48M | 37.23M | 31.37M | 32.79M | 48.27M | 28.29M | 24.11M | 41.77M | 26.55M | 34.17M |
Interest Expense | 1.45M | 1.52M | 1.98M | 1.59M | 552K | 366K | 395K | 396K | 422K | 422K |
Selling & Marketing Expenses | 4.4M | 3.7M | 3.4M | 1.7M | 1.8M | 1.7M | 7.2M | 500K | 400K | 300K |
Cost & Expenses | 54.34M | 54.53M | 51.23M | 56.44M | 71.93M | 56.05M | 36.42M | 50.03M | 37.3M | 45.02M |
Income Tax Expense | 4.13M | 4.48M | 5.14M | 3.47M | 3.58M | 13.6M | 7.42M | -7.04M | 1.94M | 1.76M |
Shares Outstanding (Basic) | 13.09M | 13.06M | 13.02M | 13.17M | 12.84M | 12.71M | 12.9M | 13.07M | 13.11M | 13.07M |
Shares Outstanding (Diluted) | 13.15M | 13.15M | 13.12M | 13.17M | 12.84M | 12.91M | 12.9M | 13.08M | 13.26M | 13.07M |
EPS (Basic) | 0.39 | 0.44 | 0.63 | -0.27 | -0.74 | 3.47 | -0.48 | -0.43 | 0.28 | -0.03 |
EPS (Diluted) | 0.39 | 0.44 | 0.62 | -0.27 | -0.74 | 3.41 | -0.48 | -0.43 | 0.27 | -0.03 |
EBITDA | 16.33M | 17.31M | 15.28M | 9.46M | 2.2M | 58.93M | 2.69M | -10.18M | 6.86M | 2.66M |
EBIT | 10.75M | 11.75M | 15.24M | -2.07M | -5.32M | 58.03M | 1.62M | -12.26M | 5.97M | 1.76M |
Depreciation & Amortization | 5.58M | 5.89M | 5.96M | 4.22M | 2M | 1.2M | 1.34M | 1.16M | 1.15M | 1.15M |